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Over 17% of American children are obese. These are epidemic proportions considering 
the associated risk of heart disease and Type 2 diabetes. Excess fat is caused from an imbalance 
in energy stored versus energy expended. Previous studies of the fat cell in vitro have revealed 
differences in the lipolytic response to aerobic exercise in subcutaneous abdominal adipose tissue 
(AAT) from obese and lean adults. There is also evidence that aerobic exercise training can 
increase subcutaneous AAT lipolysis in obese adults. However, review of the literature revealed 
no studies examining the training response in subcutaneous AAT of obese children. The purpose 
of this study was to determine whether there is a lower lipolytic response to aerobic exercise in 
subcutaneous AAT of obese children. Also, we wanted to know if 16 weeks of aerobic exercise 
training would increase the lipolytic rates in subcutaneous AAT of obese children. In this study, 
we recruited children from Greenville, NC and surrounding areas. We used the microdialysis 
technique to examine the lipolytic rate of subcutaneous AAT in response to aerobic exercise in 
forty sedentary children ages 8 to 11. All children and parents were made aware of the risks and 
benefits of the procedure and signed both consent and assent forms. The study was approved by 
the East Carolina University International Review Board. Children were grouped by body mass 
index percentile into obese (n =28) or lean (n =12). Children exercised for twenty minutes at 
70% of their heart rate max.   In response to exercise, dialysate glycerol concentrations (index of 
lipolysis) increased in the obese less than the lean (8.1 ± 2.1 uM vs 17.1 ± 4.2 uM, respectively; 
p <0.05). Changes in subcutaneous AAT blood flow, measured by the ethanol outflow; inflow 
ratio, was not significantly different between the two groups. We also examined the effects of 16 
weeks of aerobic exercise training on subcutaneous AAT lipolytic response in the obese children 
(n =21). Children were trained (machines, free play) at an average heart rate of 140 bpm for an 
hour three times a week. The children returned for another microdialysis session after training. 
The treadmill speed during the exercise portion after training was the same as that used before 
training. The change in dialysate glycerol during exercise was not significantly different before 
and after training (8.9 ± 2.5 and 6.2 ± 2.8 uM respectively; p =0.37). These results suggest that, 
like adults, obese children have a lower lipolytic response to an acute bout of aerobic exercise 
than do lean. In addition, 16 weeks of training does not alter lipolytic response to aerobic 
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CHAPTER 1: Introduction 
The prevalence of obesity has increased in America. To be classified as obese, a person 
must have a body mass index (BMI) of above 30 kilograms per meter squared (A normal BMI is 
between 18 and 25 kg/m
2
). When a person reaches a large BMI, they are grouped into a high risk 
category for many diseases. One of the most prevalent is type 2 diabetes. Type 2 diabetes is 
associated with a poor response to insulin’s effect on glucose uptake. Diabetics often have 
multiple health problems that stem from obesity and insulin resistance. A recent National Health 
and Nutrition Examination Survey (NHANES) concluded that two thirds of Americans with type 
2 diabetes is also obese (Kramer, Caoa, Dugasa, Lukea, Coopera and Durazo-Arvizua 2009). 
Peripheral arterial disease, hypertension, and death are all highly correlated with obesity 
(Bjorntorp 1997). Hypertension, also known as high blood pressure, often leads to heart disease 
and the results from a recent study by Ford, Zhao, Pearson, and Mokdad (2008) concluded that 
half of hypertensive patients are also obese. Therefore, obesity is an indicator of poor health and 
diabetes alone is costing billions of dollars. The director for the Centers of Disease Control 
(CDC) called the rise of diabetes a public health emergency (CDC, 2004). A study funded by the 
CDC revealed that 32.2 percent of Americans are classified as obese and over 60 percent are 
overweight (Ogden, Carroll, Curtin, McDowell, Tabak, Flegal 2006). Entrepreneurs have targeted 
this ever growing population of the obese by creating crash or fad diets to lose this excess 
weight. These are often unhealthy ways of losing weight and do not always address from where 
the weight is lost. If weight loss is from fat free mass, as opposed to fat mass, it is not as healthy 
and therefore should not be as desirable. The truth is that diet is not the only contributing factor 
to how much someone weighs.  
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Both diet and exercise contribute to weight management. To maintain weight, a person 
must remain at a zero energy balance. A zero energy balance requires people to expend as much 
energy as they consume. The body intakes energy in the form of food and that food is broken up 
into fat and carbohydrates to be used immediately as fuel (carbohydrate) or stored as potential 
fuel in adipose tissue (fat). Protein is used mostly for structural purposes and not used for energy 
to the extent that fat and carbohydrates are used. However, any excess of these three 
macronutrients, if not used as fuel, will be stored as fat. The main point is that too much food 
intake causes fat gain. To expend energy, other than the basic function of the organs, the skeletal 
muscles must be exercised. Only a small amount of energy is devoted to the internal body organ 
functions. A much greater amount of energy is used during exercise by the working muscle. 
Exercise has, for a long time, been viewed as a potential cost effective way to combat 
weight gain or obesity. In 1996, the surgeon general announced publicly that exercise is good for 
your health. He also acknowledged that a dose response relationship exists between increased 
exercise and absence of disease. This means that a higher dose of exercise will bring more 
benefits.  Exercise is an excellent way to burn energy and combat excess fat. Exercise training 
also has many benefits. These benefits are often present without fat loss, such as strengthening 
the heart muscle and increasing the effectiveness of the lungs. Exercise training increases the 
body’s response to hormones released during exercise and improves the action of these 
hormones. Many adults have come to realize that daily exercise is important. Unfortunately, for 
some, daily exercise may not be enough. 
America now has a potentially bigger problem. According to the NHANES 2004 report, 
17.1 percent of adolescents are overweight (Ogden, Carroll et al. 2006). These children could be 
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at risk for many disease states at a very young age. Cardiovascular disease is progressive and 
these children’s mortality risk could be multiplied because of long term exposure to the negative 
effects of obesity (Coppack 2005). 
 It is still unclear whether humans are predisposed to be obese. Studies have shown a high 
correlation between family obesity and childhood obesity (Burns, Moll, Lauer 1989; Whitaker, 
Wright, Pepe, Seidel, Dietz 1997). Childhood obesity is a potent indicator of obesity in 
adulthood (Whitaker et al. 2004). It is important to study fat in children at the cellular level to 
determine if there are defects in the adipocyte (fat cell) that are evident early in life. Also, this 
population is potentially unaffected by sex hormones which may play a role in metabolism 
during adolescence.  
The review of the literature revealed that studies of lipolysis are dominated by adult 
subjects or in vitro experiments. The relationship between in vivo lipolysis and obesity in 
children is still unclear. Few studies have focused on in vivo lipolysis in children. One such 
study, by Hershberger, McCammon, Garry, Mahar, and Hickner (2004) used the microdialysis 
technique to measure lipolysis of obese and lean children in vivo during exercise. The authors 
found no difference in lipolytic rate in response to exercise between the obese and the lean 
children. However, the rates were not equal and there was a large standard deviation. Unlike 
Hershberger, our study used a relative intensity based on the of the participants’ max hr response 
during a treadmill test of maximal aerobic capacity (VO2max). 
The main question in this study is whether obese children breakdown their fat differently 
than lean children during exercise. In this study we controlled for caloric intake and fitness to 
compare obese and lean children’s fat breakdown during an aerobic bout of exercise. 
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Furthermore, this was the first study, to our knowledge, to use microdialysis of subcutaneous 
abdominal adipose tissue (AAT) in obese children to examine the effects of a sixteen week 
aerobic training program on lipolysis of the subcutaneous AAT. 
Statement of the Problem 
 The prevalence of obesity has increased dramatically in the past thirty years. Obesity is 
associated and highly correlated with disease and disease states such as Type 2 diabetes and 
cardiovascular disease. Public health costs are in the trillions and the national debt is increasing. 
Obesity is not only a health issue but a fiscal issue as well. The purpose of this study is to 
determine if obese children breakdown fat, known as lipolysis, at a lower rate than lean, perhaps 
limiting the availability of fat for energy during exercise. 
Purpose 
 There are two aims of the present study. Aim one examined the response in subcutaneous 
AAT of obese and lean children to an acute bout of exercise. Aim two examined the effects of 16 
weeks of aerobic exercise training on the lipolytic response in subcutaneous AAT of obese 
children to an acute bout of aerobic exercise. 
Research Hypothesis 
We hypothesized that (a) obese children would have a lower lipolytic response to an 
acute bout of exercise when compared to lean children and (b) obese children would raise their 




The following terms have been clarified for the purpose of this study: 
BMI: the body mass index is calculated from a ratio between height in meters squared and 
weight in kilograms. 
Obese: defined as having a BMI above the 95th percentile when compared to other children of 
the same age and gender. 
Lean: defined as having a BMI below the 80th percentile when compared to other children of the 
same age and gender. 
Lipolysis: metabolic pathway that separates fatty acids from a glycerol “backbone” inside the 
adipocyte. 
Sedentary: children who did not participate in more than 30 minutes of deliberate exercise three 
or more times a week. 
VO2max: the maximal amount of oxygen that can be utilized during maximal exercise intensity. It 
is the standard criterion for the measurement of health fitness. 
Acronyms: 
The following acronyms may be used for brevity in this study: 
CDC: Centers for Disease Control and Prevention 
NHANES: National Health and Nutrition Examination Survey 




FA: Fatty acid 
TG: Triglyceride 
ATBF: Arterial blood flow 
Limitations/Delimitations 
The limitations of the study include the following: 
1. Neither arterial nor subcutaneous AAT catecholamine concentrations, at rest or exercise, 
were measured. 
2. Arterial glycerol (indicator of whole body lipolysis) concentrations were not measured 
during exercise. 
3. Participants were not fasted during exercise. 
Clinical Relevance 
 It may be that the obese do not oxidize fat, originating from the subcutaneous AAT, as 
preferably as the lean.  Defects may be present in the metabolic pathway of subcutaneous AAT. 
Knowledge of these defects is necessary to propose strategies to maximize fat utilization. It is 
possible that alternative treatment, along with exercise and proper diet, is necessary to control 
weight and over fatness in the obese. 
  
  
CHAPTER 2: Literature Review 
The number of obese children in the United States is reaching epidemic proportions. 
Now, over 17% of children in America are obese (Ogden, Carroll et al. 2006). This study 
attempts to investigate this rise in obesity by observing processes inside the adipocyte. This 
review of literature will focus on research in the following areas: (a) obesity and associated 
health risk, (b) measuring lipolysis of the adipocyte using the microdialysis technique, (c) 
adipocyte response to acute exercise and (d) aerobic training. 
Obesity and Health 
 Obesity in America has become a serious public health issue that seems to be getting 
worse. According to a study by Flegal et al. (1998), obesity increased markedly from 14.1% in 
1980 to 22.4% in 1994. The NHANES III report showed that this has increased to 32.2% for 
adults. This increase is also evident in children. According to the same survey, the incidence of 
childhood obesity has reached 17.1% (Ogden, Carroll et al. 2006).  
Obesity is determined by the Body Mass Index (BMI): the ratio between weight and 
height. For adults, a BMI measurement above 30 kg/m
2
 defines obesity. For children, the BMI is 
compared with other children of the same age and sex. Above the 95th percentile is classified as 
obese and below 80th percentile is classified as lean as indicated by Kuczmarski, Ogden, Guo, 
Grummer-Strawn, Flegal, Mei, et al. (2002). These numbers have been developed from the 
surveys administered by the National Health and Nutrition Examination Survey (NHANES I, 
NHANES II, NHANES III), National Health Survey (NHES) II, and NHES III.  Though body fat 
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percentage is probably the best measurement to evaluate over fatness, obtaining the body fat 
percentage is often expensive or laborious.  
Using BMI to determine obesity is easy and non invasive. Must, Dallal, and Dietz, (1991) 
explored the initial classification of BMI and its reliability in determining obesity. Dietz used 
NHANES I data collected from 1971 through 1974 to develop percentiles based on age, race, 
and gender. The authors concluded that children above the 95th percentile were obese and at risk 
for disease. 
Dietz and Bellizzi (1999) investigated the validity of using the BMI to determine excess 
fat in children. They compared data obtained from previous studies to correlate body fat % 
measured from hydrostatic weighing or DXA and body fat % measured from BMI. Hydrostatic 
weighing is the gold standard and techniques such as Dual X ray Absorptiometry (DXA) can 
distinguish between bone, lean tissue, and fat tissue (Gutin et al. 1996). They found that whether 
hydrostatic weighing or DXA was used, both were highly correlated with BMI. Though all 
methods have limitations, Dietz and Bellizi concluded that the use of BMI is an acceptable 
measure to determine body fatness in children.  
Obesity causes a spillover of fatty acids from the adipocyte that circulate in the blood 
plasma. Spillover begins after the adipocyte fills to capacity with triglycerides (TG) and fatty 
acids (FA). Previous studies show that these extra TGs and FAs, if not used as fuel, interfere 
with signaling inside the adipocyte causing physiological changes in the adipose tissue. Obesity, 
excess FAs, glucose intolerance, and insulin resistance are all central players in the development 
of type 2 diabetes (Coppack 2005).Type 2 diabetes is becoming more prevalent in America as 
well. Once thought of as a progressive disease in adulthood, type 2 diabetes is now found in 
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obese children (Fagot-Campagna, Pettitt, Engelgau, Burrows, Geiss, Valdez, et al. 2000). Insulin 
resistance is also a central factor in the Metabolic Syndrome. This syndrome is characterized by 
obesity, insulin resistance, dyslipidemia, hypercholesterolemia, and hypertension. It is a 
grouping of risk factors that may indicate a high risk of developing diabetes, cancer and/or 
cardiovascular disease.  
Excess FAs may also interfere with the DNA of the cell by altering gene expression. This 
is true for many different types of cells including the hepatic cells. The liver begins to function 
differently because of the excess fat storage and this has been linked to non alcoholic fatty liver 
disease (Malhi, Gores 2008). Recent studies suggest that these excess FAs eventually take a non 
oxidative pathway and begin to create reactive species that are toxic to the cell. If toxic enough, 
the cell will undergo apoptosis or death (Kusminski, Shetty, Orci, Unger, Scherer 2009). 
 These alterations in the adipocyte may start in early childhood as suggested by Whitaker 
(2004) who examined longitudinal data of obese and lean subjects from childhood through 
adulthood. The authors concluded that childhood obesity increases the chance of being obese as 
an adult. This makes childhood obesity a potent indicator when predicting obesity. Other studies 
have shown an equal contribution of genetics and lifestyle. Burns, Moll, and Lauer (1989) 
evaluated the relationship between family obesity and childhood obesity. The purpose of the 
study was to assess the contribution of genes and environment to adult obesity. Subjects were 
recruited from Muscatine, Iowa and examined over a four year period. BMI and CVD risk 
markers were evaluated throughout the study. A regression analysis revealed that genetics 
account for about 50% of the variance in BMI and that environmental factors accounted for the 
other 50%. The authors concluded that both genetics and environment contribute equally to 
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childhood and subsequently adulthood obesity. Results from studies examining the contribution 
of childhood obesity to adulthood obesity remain unclear. 
The distribution of fat has also emerged as a consideration when assessing for the 
Metabolic Syndrome. The reason that obesity is associated with many diseases is because a BMI 
above the 95th percentile most often indicates a disproportionate amount of fat mass when 
compared to fat free mass. It is the excess fat, and not muscle, that correlates highly with disease 
states. Much of this excess fat is stored in the subcutaneous adipose tissue of the body. Some 
depots can grow very large such as in the abdomen.  
Abdominal obesity is recognized as a risk factor in the Metabolic Syndrome. Larsson, 
Svardsudd, Welin, Wilhelmsin, Bjorntorp, and Tibblin (1984) examined middle aged men 
chosen by the birth year of 1913 in Gothenburg, Sweden. Anthropometric data was obtained in 
1967. 13 years later all men were re evaluated to see who had died from a stroke. Abdominal 
obesity, as opposed to general obesity, was more associated with risk of having a stroke. The 
results indicate that abdominal obesity was a strong (and independent) indicator of 
cardiovascular disease risk. This is also in agreement with a discussion by Per Bjorntorp (1997) 
that points to central obesity as having a greater correlation with cardiovascular disease than 
generalized obesity. 
Central fat depots are common in obese adults. Is excessive central fat accumulation also 
common in children? Studies are dominated by the use of adult subjects because children are 
often disease free. However, children with excess fat are becoming more common. The ones who 
are obese have a higher incidence of type 2 diabetes and often progress to other diseases that in 
the past have been more commonly associated with adulthood obesity. However, whether these 
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alterations in lipolysis of the obese are modifications of the adipocyte or inherent from birth is 
unclear. Studies in adults have suggested that the obese have lipolytic alterations of the 
subcutaneous adipose tissue in places such as the abdomen and these central obesity is also seen 
in children (Arner 2005; Meininger, Brosnan, Eissa, Nguyen, Reyes, Upchurch et al. 2010). The 
review of literature has not revealed enough information on the lipolytic response of 
subcutaneous AAT in children. 
Measuring Lipolysis 
 FAs are stored as TGs inside the adipocyte and wait to be released for energy. Before 
release the adipocyte undergoes a cascade of events known as lipolysis. The FAs are hydrolyzed 
off of their glycerol backbone by adipose tissue TG lipase (ATGL) and hormone sensitive lipase 
(HSL) so that they can be moved across the adipocyte membrane. The glycerol is transported 
directly to the liver via the bloodstream. Here, the glycerol is used to make another TG or to be 
converted to glucose. The FAs, however, have many possible fates. They may be re-esterified 
and moved back into an adipocyte for storage but they are also free to move into the blood 
stream for transport to the muscle or liver. In the muscle, the FA is oxidized for energy used in 
contraction. The liver stores the FA by creating new TGs (Arner 2005). A consequence of this 
unidirectional movement of glycerol out of the adipocyte is that it can be obtained and measured 
as an indicator of lipolysis. The microdialysis technique, developed originally for brain tissue of 
rats, has been adjusted for use in human tissue. The procedure allows for the measurement of 
metabolites in the extracellular fluid in muscle or adipose tissue (Lonnroth, Smith 1987; 
Ungerstedt 1991). This led investigators to a host of questions about local metabolism in tissues 
of humans. Adipose tissue is not easily accessed by catheterization of a major artery and vein for 
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traditional arterio-venous measurements, so the microdialysis methodology was often used in 
this tissue. 
Studying fat in vivo in humans is relatively in its infancy. Early work in rats utilized the 
microdialysis method to measure glycerol released from fat.  A study by Arner, Bolinder, Agneta 
Eliasson, Lundin, and Ungerstedt (1988) used microdialysis probes inserted into the fat tissue of 
male Sprague-Dawley rats to collect glycerol released into the extracellular space. This study 
showed successful microdialysis of the subcutaneous fat tissue of rats. Furthermore, it showed 
that continuous monitoring of the tissue over time was also possible (Arner et al. 1988). These 
results were found in rats and more studies were needed to assess how well the data translated to 
humans. 
  Lonnroth and Smith (1990) wrote an article explaining the usefulness of the microdialysis 
technique and its implications for measuring metabolites continuously in vivo in humans.  Arner, 
Kriegholm, Engfeldt, and Bolinder (1990) used the microdialysis technique to monitor 
metabolites in local subcutaneous adipose tissue sites in vivo in humans. Both studies concluded 
that the technique is valid for in vivo experiments. Wahrenberg, Bolinder, and Arner (1991) 
wrote a review explaining that the microdialysis technique could be used for continuous 
monitoring of metabolites such as glycerol from human adipose tissue. The authors explain the 
non invasive nature of the procedure and the fact that it causes little discomfort. Because of the 
advances in microdialysis technology, the authors determined this technique to be valid for 
adipose tissue experimentation. Common sites for insertion of the probe are the abdominal and 
the femoral region. 
Adipocyte Response to Exercise 
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Increasing lipolysis is necessary to provide energy to meet the physical demands of the 
body, especially during prolonged exercise lasting over fifteen minutes. The rate of lipolysis is 
not equal to the rate of fat oxidation, but lipolysis is necessary to move the fat from a stored state 
to an active one capable of being used to generate ATP for the functions of the cell. Like many 
other cells in the body, the adipocyte is regulated by hormones. Receptors, expressed on the 
outside of the cell, are activated like a key in a lock. The control of lipolysis, like many 
metabolic pathways, is quite complex and the chemistry is not discussed in detail here. However, 
previous studies have shown that the adipocyte has both stimulatory and inhibitory regulation. 
Two of the major controls of lipolysis in fat tissue include its response to insulin and 
catecholamine (Arner 2005; Coppack 2005). 
Insulin receptors, when activated, will inhibit lipolysis (Arner, Bolinder, Engfeldt, 
Ostman 1981; Coppack, Patel, Lawrence 2001). Insulin’s antilipolytic effect on the adipocyte is 
well known and beyond the scope of this review. The focus will remain on catecholamine 
mediated receptors expressed on the adipocyte and they are the alpha2adrenergic and the beta 
adrenergic receptors (Alpha2 AR and Beta AR respectively).  
Evidence for the alpha2 ARs expressed on animal adipocytes was found in the 1980s 
(Berlan, Lafontan 1980). Lafontan and Berlan (1980) also explored the nature of the alpha2 ARs 
and their role in lipolysis. They found that alpha2 ARs in animals had an affinity for 
catecholamine which is a neurotransmitter released from the nervous system.  When 
catecholamine binds with the alpha2 ARs, lipolysis will slow. Alpha2 ARs antilipolytic effect on 
lipolysis in adipose tissue is well defined (Lafontan, Berlan 1981). 
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Alpha2 ARs are counter to the beta ARs. Beta ARs were also discovered to be expressed 
on human adipocytes. The beta ARs have an affinity for catecholamine much the same as the 
alpha2 ARs. However, the beta ARs increase lipolysis when bound to catecholamine whereas the 
alpha2 ARs inhibit lipolysis when bound to catecholamine. In vitro experiments on adipocyte 
biopsies have revealed the affinity of these two receptors for the catecholamine in humans (Fain, 
Garcia-Sainz 1982; Mauriege, De Pergola, Berlan, Lafontan 1988).  
Keller, Weiss, and Stauffacher (1989) wanted to study the contribution of alpha2 and beta 
ARs to the lipolytic effects of catecholamine in humans. The investigators used fat from biopsies 
to compare the alpha2 and beta ARs in vitro. The authors found that both the alpha2 ARs and the 
beta ARs have an affinity for catecholamine. The importance of the beta ARs in regulation of 
whole body lipolysis was investigated by Wahrenburg, Lonnqvist, Hellmer, and Arner (1992). 
Low levels of the catecholamine promote alpha2 inhibition. Higher levels of catecholamine 
promote beta AR upregulation. These results, found in vitro, were reproduced in vivo in healthy 
adult males (Barbe, Galitzky, Riviere, Senard, Lafontan, Garrigues, et al. 1993; Lonnqvist, 
Wahrenberg, Hellstrom, Reynisdottir, Arner, 1992). It is clear that there is a constant battle 
between the adrenergic receptors because they both have an affinity for catecholamine.  During 
exercise, these catecholamines are released in abundance to speed the heart rate and move the 
blood rapidly around the body.  This is also the way the body signals the adipocyte to release its 
stores of energy. Fat has approximately double the potential energy when compared to 
carbohydrates and increasing lipolysis is a favorable response to utilize fat during exercise. 
Catecholamine binds with the adrenergic receptors of the adipocyte so that it will release its FAs 
from glycerol. They are then moved to the plasma to be delivered to the working muscle 
(Horowitz 2003; Stitch, Berlan 2004).  
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Savard, Despres, Marcotte, Theriault, Tremblay, and Bouchard (1987) examined the 
effects of acute aerobic exercise on adipocyte lipolysis in fat tissue obtained from biopsy of the 
subcutaneous adipose tissue. Biopsies of fat were taken from the abdomen and gluteal region 
before and after aerobic exercise. Adipocytes from both depots were incubated in epinephrine. 
Glycerol levels post-exercise were significantly higher than pre-exercise in vitro. This study 
showed that there is an acute adaptation of the adipocyte in response to exercise. These results 
are in agreement with Wahrenberg, Engfeldt, Bolinder, and Arner (1987) who also showed acute 
changes in adipocyte lipolysis such as increased glycerol release in response to exercise.  These 
acute adaptations are attributed to the response of the beta ARs to catecholamine release. Since 
the alpha2 receptors have a higher affinity to catecholamine at lower physiological 
concentrations, beta ARs are more important during exercise when higher concentrations of 
catecholamine are present. An admitted limitation to the in vitro experiments is that the 
adipocyte is removed from its true environment. 
  Catecholamine is released during exercise relative to the intensity of the exercise. The 
general consensus is that increasing intensity will increase the amount of catecholamine released. 
It is clear that higher concentrations of catecholamine are needed to increase lipolysis by 
activation of the beta ARs. This is also true in local sites such as the subcutaneous AAT (Berlan 
et al. 2010; Galitzky et al. 1998). Intensity, catecholamine release, lipolysis, and fat oxidation are 
all linked in the process of metabolism in both healthy and overweight adults (Pillard, Moro, 
Harant, Garrigue, Lafontan, Berlan, et al. 2007). 
Before the microdialysis method, studies used arterial blood plasma samples to examine 
the effect of intensity on catecholamine release. These studies showed that twenty minutes of 
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moderate (~50% VO2max) exercise was needed to increase catecholamine concentrations.  The 
increase is moderate at first but rises sharply after about 75% of VO2max (Christensen, Galbo, 
Hasen et al. 1979; Christensen, Sonne et al. 1985). Blood samples, taken for hormone analysis, 
were obtained from the arterial bloodstream. Though the catecholamines are delivered via the 
bloodstream to the adipose tissue, these studies did not answer the question of catecholamine 
response of lipolysis to exercise specifically in subcutaneous adipose tissue. 
Hodgetts, Coppack, Frayn, and Hockaday (1991) examined lipolysis and FA release 
during exercise at different intensities. They recruited healthy adults to examine exercise 
intensity and fatty acid mobilization. Subjects exercised at workloads corresponding to 50-70% 
of their VO2max. Interstitial fluid from the subcutaneous adipose tissue was collected by 
catheterization as opposed to the microdialysis method. The authors found that glycerol, FAs, 
and catecholamine all rose similarly in response to different workloads. 
Arner et al. (1990) studied the local lipolytic activity of subcutaneous adipose tissue in 
the abdominal and gluteal region. Dialysate fluid was collected in vivo through the microdialysis 
technique. Probes were perfused with either saline or a selective blocking agent. Arner also 
collected data continuously while the subjects transitioned from rest to exercise. The authors 
found that the abdominal depot was more sensitive to catecholamines than the gluteal depot. 
They also observed that lipolysis was regulated differently depending on whether the subject was 
at rest or exercise. Perfusion of a beta-adrenergic receptor blocker had no effect on lipolysis at 
rest but decreased it during exercise. Perfusion of an alpha AR receptor blocker increased 
lipolysis during rest but had no effect during exercise. They concluded that alpha2 AR inhibition 
is dominant at rest but the beta ARs dominate during exercise.  These results are in agreement 
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with later studies that observed the importance of alpha2 and beta ARs in controlling lipolysis in 
vivo (Barbe, Millet, Galitzky, Lafontan, Berlan 1996; Coppack, Jensen, Miles 1994). 
Galitzki et al. (1998) investigated local action of catecholamines on subcutaneous adipose 
tissue. Subjects were healthy weight and young. Microdialysis of the subcutaneous adipose tissue 
allowed perfusion of catecholamine directly to the local site. Catecholamines increased the 
concentration of glycerol in the subcutaneous adipose tissue. The increase in glycerol was shown 
to be catecholamine concentration dependant. Also, the subjects were re-tested at a later date 
with no perfusion of drugs. Instead the subjects were asked to move from a supine to an upright 
position (active tilt) for twenty minutes. Catecholamines were increased during active tilt and 
interstitial glycerol levels also rose. This study showed that catecholamines do play a role in 
local tissue depots such as subcutaneous adipose tissue.  
A recent study by Glisezinski, Larrouy, Bajzova, Koppo, Polak, Berlan, et al. (2009) used 
microdialysis of the subcutaneous AAT tissue to investigate the difference in response to 
catecholamines by the beta ARs of the adipocyte. Subjects underwent an exercise session of 
sixty minutes at 50% of their VO2max. The authors concluded that adrenaline (epinephrine), and 
not noradrenaline (norepinephrine), is the main effecter of lipolysis via the beta ARs.  
Adipocyte function is altered in the obese. These changes could be evident in physical 
attributes of the cell such as the size (adipocyte hypertrophy) or in functional attributes of the cell 
(impaired signaling). In obesity, the adipocyte hypertrophies because it continues to fill with TGs 
during energy imbalance. These cells will decrease in size in subjects who experience weight 
loss suggesting that the alterations are a transient effect (Coppack 2005). There is also evidence 
that there is a heterogeneous number of alpha2 and beta ARs expressed on the adipocyte and 
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larger adipocytes have been shown to correlate higher with expression of alpha2 inhibitors 
(Mauriege, Galitzky, Berlan, Lafontan 1987). The obese have more fat mass so it is likely that 
they will have more whole body lipolysis in absolute terms. When data are expressed per gram 
of fat, the obese have a lower rate of lipolysis when compared to the lean. Locally, in areas such 
as the subcutaneous AAT, the lipolytic rates can also differ between obese and lean adults. 
Physical differences in adipocytes of obese and lean led investigators to hypothesize that 
there would be a difference in lipolysis between obese and lean individuals. Jansson, Larsson, 
Smith, and Lonnroth (1992) measured glycerol concentrations of subcutaneous adipose tissue in 
lean and obese men. The purpose of the study was to investigate differences of subcutaneous 
adipose tissue lipolysis in lean and obese men at rest. Subjects underwent the microdialysis 
procedure so that glycerol could be measured as a rate of lipolysis. The authors concluded that, at 
rest, the larger adipocytes of the obese had a higher lipolytic rate than the smaller cells of the 
lean. 
Differences in lipolytic rates at rest of the obese and lean, led investigators to hypothesize 
that the adipocyte of subcutaneous AAT in obese individuals would respond differently than the 
lean during aerobic. Mittendorfer, Fields, and Klein (2003) recruited both lean and obese 
subjects to study the rates of lipolysis and fatty acid release during exercise. Subjects were 
determined by BMI to be lean, overweight, or obese. All subjects performed an aerobic exercise 
bout on a cycle ergometer at about 50% of VO2max. Results of this study showed an inverse 
relationship between body fat mass and levels of glycerol (r
2
 =.74). There was also an inverse 
relationship between body fat mass and FA release (r
2
 =.69). This study suggests that increased 
body fat is associated with a reduced lipolytic rate, which limits the availability of FAs to be 
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used for oxidation. It has been suggested by Madsen, Bulow, and Nielsen (1986) that, because 
there is a large amount of FAs in the circulating blood, there is no need for the obese to increase 
lipolysis in subcutaneous AAT during exercise. According to Mittendorfer et al. (2004), the 
obese also oxidize less fat than the lean during exercise. It is possible that both Madsen et al. 
(1986) and Mittendorfer et al. (2004) are correct and the obese both (a) use less fat to exercise, 
and (b) the fat used does not originate from the subcutaneous adipose tissue. Unfortunately, these 
results do not address in vivo measurement of subcutaneous AAT  
Stich, Glisezinski, Crampes, Hejnova, Cottet-Emard, et al. (2000) examined the effect of 
adrenergic regulation on the lipolytic rate of subcutaneous adipose tissue in lean and obese 
subjects during exercise. Results showed that the rate of glycerol appearance was lower in the 
obese subjects when compared to the lean. The authors also explored the relative contributions of 
the beta ARs and alpha2 ARs during exercise and concluded that the alpha2 AR inhibitors are 
activated during exercise in the obese. This does not appear to be true with the lean, which seem 
to have no activation of the alpha2 inhibitors during exercise or their activation is overridden by 
the overwhelming effects of the beta AR agonist. This activation of alpha2 inhibitors causes a 
lower lipolytic response to exercise in obese adults. Whether this holds true for children is still 
unknown.  
Hershberger et al. (2004) used the microdialysis technique to measure the lipolytic 
response of lean and obese children. All children performed an acute bout of exercise at a heart 
rate of 140 beats per minute for about 20 minutes. Results showed no significant glycerol change 
between the lean and obese children in response to exercise. However, the study points out that 
different speeds were needed to elicit the 140 beats per minute in the obese and lean. On average, 
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the lean required a higher speed than the obese. This difference in speed could indicate a 
discrepancy in the work intensity between the two groups. This discrepancy could alter the 
response of subcutaneous adipose tissue to the effects of catecholamines during exercise. Though 
Hershberger et al. (2004) found no differences in the obese and lean children’s lipolytic rate in 
response to exercise, there is evidence that obese children have a lower plasma catecholamine 
response to exercise (Eliakim, Alon, Nemet, Zaldivar, McMurray, Culler, Galassetti, Cooper 
2006).  More studies are needed to investigate these differences in exercise response between 
obese and lean children. 
Training Effects on Lipolysis of Obese 
Aerobic exercise training has been shown to cause many physiological changes in 
humans. The body adapts to stressors like exercise by increasing the availability or the sensitivity 
of stress controllers (e.g., hormones, catecholamines). This is true for both lean and obese 
individuals. These adaptations happen acutely as shown by Savard, Despres, Marcotte, Theriault, 
Tremblay, and Bouchard (1987). They also happen with long term training. Exercise training has 
been recognized as a positive effecter on fat loss and many mechanisms are utilized to enhance 
fat loss by increasing lipolysis and fat oxidation for fuel (Bjorntorp 1992; Lafontan, Berlan 
1993). 
. Another study by Horowitz (1999) examined the lipolytic rate of healthy men at rest 
both before and after aerobic exercise training. Results indicate that healthy men do not alter 
their resting lipolytic response after aerobic exercise training. Many in vitro studies have used 
the adipocyte to examine adipocyte response to exercise training.  Despres, Bouchard, Savard, 
Tremblay, Marcotte, and Theriault (1984) used fat biopsies of subcutaneous adipose tissue both 
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before and after an aerobic exercise training program. Improved aerobic capacity from exercise 
training caused adaptations in the adipocyte marked by an increased lipolytic rate found in vitro. 
Deuster, Chrousos, Luger, DeBolt, Bernier, Trostmann, Kyle, Montgomery, and Loriaux (1989) 
examined catecholamine responses of trained and untrained men. All participants performed an 
exercise bout and the hormones from plasma were measured. Results show that exercise trained 
individuals required less sympathetic activity to perform at any given absolute workload as 
compared to untrained individuals. Trained individuals were also able to exercise longer.  
Despres et al. (1984) also explored the effect of increasing training status of obese men 
and women to examine the response of the adipocytes to twenty weeks of aerobic exercise 
training. The results show that the adipocytes of both men and women increased lipolytic rate 
after exercise training when the cells were exposed in vitro to epinephrine. These results are in 
agreement with Deuster et al (1989) in that they agree that training status increases lipolysis. It is 
believed that training increases the response by the beta ARs and perhaps increases the ratio of 
beta ARs to alpha2 ARs during acute exercise. Some studies have shown a decreased 
sympathetic response to the same absolute intensity during exercise after aerobic training. Other 
investigators have reported an increase in sympathetic catecholamine release in response to 
exercise after aerobic training. Results found by Greiwe, Hickner, Suresh, Cryer, and Holloszy 
(1998) suggest that higher levels of catecholamine were observed when the participants 
exercised at the same relative intensity after 10 weeks of training. These studies appear to have 
differing results. In reality, they all agree that measuring lipolysis or catecholamine response to 
training is highly dependent on the intensity used during the measurement. Evidence of the 
effects of training on the ARs of the adipocyte in obese individuals was observed recently in 
vitro (Stich et al. 1998). In vitro studies built a foundation of knowledge but they remain inept at 
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describing in vivo situations. The use of microdialysis is unique; allowing in vivo measurement 
of lipolysis in subcutaneous adipose tissue and specifically the subcutaneous AAT.  
Riviere et al. (2003) hypothesized that aerobic training would improve the lipolytic 
response of subcutaneous adipose tissue in obese men. Subjects were initially sedentary before 
starting the training period. Subjects trained four months with a protocol that increased exercise 
intensity as time increased. Lipolysis was measured by the microdialysis technique before and 
after training. Glycerol release was higher in the obese subcutaneous adipose tissue post training 
when compared with levels before the intervention. Alpha blockade before training increased 
glycerol release but had no effect after the intervention. Authors concluded that the obese 
subcutaneous adipose tissue lipolysis is lower due to increased alpha2 inhibition during exercise 
(an effect not seen in the lean). With training, the obese were able to reduce the inhibition of 
alpha2 AR inhibitors and perhaps upregulate the beta AR agonist when performing an acute bout 
of aerobic exercise. This lack of alpha2 AR inhibitors has been seen in other studies examining 
lipolysis and training status in normal weight males (Riviere et al. 2001). 
Richterova et al. (2004) hypothesized that aerobic training of obese women would alter 
the lipolysis of subcutaneous adipose tissue. Phentolamine (alpha receptor blocker) infusion 
allowed examination of the adrenergic response to training. Phentolamine infusion before 
training resulted in a significant increase in glycerol levels of subcutaneous adipose tissue. This 
increase was not observed during phentolamine infusion after the increase in aerobic capacity. 
Results suggest that alpha2 AR inhibition during exercise in obese women can be reduced with 
aerobic training. However, unlike other studies that suggest a lack of expression of alpha2 ARs in 
adipocytes after training, this study suggests that training increases the delivery of catecholamine 
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in the plasma and not the sensitivity to the catecholamine by the adipocyte. Another study 
showed that exercise training increased the beta AR response to the catecholamine released in 
subcutaneous AAT in obese males (Stich, Glisezinski, Galitzky, Hejnova, Crampes, Riviere, et 
al. 1999). These conclusions were also made by Glisezinski, Crampes, Harant, Berlan, Hejnova, 
Langin, et al. (1998) who also showed that, with training, the obese can increase their 
responsiveness to catecholamine by the beta ARs while also blunting the antilipolytic effects of 
the alpha2 ARs. Whatever the mechanism, it is clear that aerobic training causes lipolytic 
changes in adults. These changes may increase the body’s ability to use fat during exercise. 
There is evidence showing that overweight men can increase their fat oxidation after a four 
month endurance training program (Crampes, Marion-Latard, Zakaroff-Girard, Glisezinski, 
Harant, Thalamas, et al. 2003) 
Aerobic training adaptations are also evident in children. However, the review of 
previous literature provided no studies of training changes in lipolysis of the subcutaneous 
adipose tissue in obese children. This study aims to add to this body of knowledge by measuring 
the change in glycerol concentration in subcutaneous AAT of obese children and comparing 
them with the concentration change of lean children when exercising at the same relative 
intensity. The glycerol changes in response to an acute bout of exericse both before and after a 
16 weeks of aerobic exercise training were also measured to determine the effects of aerobic 
training on subcutaneous AAT lipolysis of obese children. 
  
  
CHAPTER 3: Methodology 
Aim 1 
Participants 
Forty sedentary children between the ages of 8 and 11 were recruited from Greenville, 
NC and surrounding areas. Children were classified as obese (n =29) or lean (n =12) when 
compared to other children their age. Also, some of the obese (n =21) were randomly assigned 
into an exercise intervention group. Those children participating in more than thirty minutes of 
deliberate exercise each day for three days a week prior to the procedure were excluded. 
Children were prepubescent and did not exceed Tanner stage 2. No children were on any 
medications that targeted blood flow. 
Preliminary Testing 
  The participants initially met at the East Carolina University (ECU) FITT building with 
their guardian to sign an informed consent (see Appendix B). Because the participants are 
children, it was necessary for the children and the parents to sign an assent form explaining the 
risks of the procedure (see Appendix C). Participants were paid a 50 dollar check for the 
procedure and a 25 dollar gift card from a local Greenville, NC vendor (compensation for the 8 
hour monitoring in the FITT lab). This study was approved by the East Carolina University 




 Height was measured with a stadiometer, and weight was measured using a Cardinal 
Detecto digital scale (model #708, Webb City, MO, USA). BMI was calculated from the weight 
in kilograms divided by the height in meters squared. Obese were classified as being above the 
95th percentile and lean were classified as being below the 80th percentile when compared to 
other children their age, gender, and race as indicated by Kuczmarski (2002). The website used 
to determine percentile ranking can be found at www.cdc.gov/growthcharts.  Participants were 
also evaluated by DXA (QDR-1000/w, Hologic, Inc., Waltham, MA) for the purpose of 
determining body fat percentage. The DXA machine is a three compartmental system that can 
distinguish between bone, fat, and lean tissue (Gutin et al. 1996). All obese children had a body 
fat percentage above 40%. The lean children had a body fat percentage below 28%. On this visit, 
the participants were also familiarized with the treadmill equipment in anticipation for the 
maximal oxygen uptake (VO2max) treadmill protocol.  
VO2max Protocol 
 Participants performed a VO2max treadmill protocol (see Appendix D) on a separate visit 
to the ECU FITT lab. All participants performed at least two VO2max tests. If the results were not 
within 4%, another test was performed for a maximal of three. Oxygen uptake was determined 
by indirect calorimetry using the Parvo-Medics metabolic cart. Maximal.VO2 was calculated by 
averaging the two closest results. Heart rate was obtained using the Polar Heart Rate Monitor 
with Cheststrap. Maximal heart rate was determined to be the highest heart rate achieved during 
any of the three VO2max tests. Children were asked to rate their perceived exertion on a modified 
Borg Scale. This scale ranged from one as the lowest exertion to ten as the highest exertion. 




Participants arrived at the ECU FITT building on a Saturday morning after an overnight 
fast. The children were greeted and brought to the exam room and instructed to lay supine on the 
examination table for a procedure called microdialysis. The microdialysis technique has been 
used as a minimally invasive surgery with an insertion of a probe into both muscle and adipose 
tissue (Bolinder, Danielle, Kerckhoffs,  Moberg, Hagstrom-Toft, Arner 2000; Lonroth et al. 
1990). The probe allows certain sized metabolites such as glycerol to penetrate its semi-
permeable membrane. The area 2 cm from the umbilicus is sterilized with iodine swabs. 
Coldspray (ethyl chloride) is applied directly for topical anesthesia before an 18g catheter, fitted 
with a probe guide, is inserted into the child’s subcutaneous AAT and between the adipocytes. 
The needle is removed leaving the guide behind. The microdialysis probe (CMA 20 elite 14cm 
inlet tubing, 10 cm outlet tubing, PAES membrane with 20.000 Dalton cutoff. Solna, Sweden) 
was then inserted into the guide before the guide itself was removed. All that remains under the 
skin is the probe. This probe is secured with steri-strips and Tegaderm. 
Sample Collection 
Saline, and a known amount of ethanol (5 mmol/L), was perfused at a rate of 2 µl/min 
through the inserted probe using a CMA/Microdialysis 107 pump (Stockholm, Sweden). The 
fluid was perfused through the probe tubing and collected by a 300 µl CMA/Microdialysis 
plastic microvial placed on the exit tubing of the microdialysis probe.  This fluid in the collection 
vial (termed dialysate) is measured for concentrations of glycerol. 
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These collection vials were obtained every hour in a controlled environment at the ECU 
FITT building. The children remained sedentary until it was time for the acute exercise portion 
of the day. Activity was be limited to board or video games and movies. Activity was measured 
by the Actigraph GT1M dual axis accelerometer during the 8 hour microdialysis visit. This 
accelerometer has been validated as a way to track activity and step count in children (Crouter et 
al. 2010). 
Sample Analysis 
After collection, samples were immediately capped and placed into a 4° Celsius 
refrigerator for storage. After all samples are collected, they were moved from a 4°C refrigerator 
to a -20°C freezer until they are measured for ethanol and glycerol concentrations. The ethanol 
outflow/inflow ratio (O:I ratio) was used to monitor changes that may occur in local blood flow 
(Bernt, Gutmann 1974; Hickner et al. 1991). Glycerol concentration was measured in duplicate 
by the CMA/600 automated analyzer (Chemical Microdialysis Analyzer, Stockholm, Sweden). 
Diet 
The children were fed a calorically controlled meal 1.5 hours prior to performing an acute 
bout of aerobic exercise. The meals were based on percentages of the three macronutrients: 
carbohydrate, protein, and fat (65%, 15%, and 20% respectively). The total caloric intake was 
based on the child’s body composition, weight, and age. The participants were able to choose 
from a list of pre packaged meals (Lunchables). They were instructed to finish the entire meal 




The exercise took place one and a half hours after breakfast. The time of exercise was 
always twenty six minutes on a Lifefitness 93ti Dualshock treadmill. The total minutes included 
a three minute warm-up and a three minute warm-down. The children walked (or jogged) on a 
treadmill at an intensity of 70% of their measured maximum heart rate (see Appendix E). This 
intensity was calculated using the child’s maximal heart rate obtained from the VO2max test. 
During the acute exercise, the treadmill speed was adjusted to maintain a heart rate 
corresponding to 70 % of the participant’s heart rate maximum  
Aim 2 
Participants 
 The same obese children (n =21) examined in aim one were also used to test the 
hypothesis for aim two. These children received 16 weeks of aerobic exercise training. They 
returned to the FITT building (post testing) after the intervention for another examination of 
lipolysis. 
 Training Protocol 
Each week the children set up a schedule that included 180 minutes structured activity 
monitored by an exercise trainer. Children met with trainers at the ECU FITT building for 
activities that included exercise machines (e.g., treadmill, cycle) and free play (e.g., soccer, 
jumprope). Participants exercised for an hour three times per week. Their heart rate, measured by 
a Polar heart rate monitor, was kept at an average of 140 heart beats per minute each hour 




After 16 weeks of aerobic exercise training, the obese children came back in for another 
body composition and another VO2max test for fitness. Children also came back to the FITT 
building for another microdialysis procedure. All efforts were made to repeat the day they had 
during the first microdialysis, including the time of the procedure. The children consumed the 
same meal they had on the first microdialysis visit during their 16-week follow-up visit. The 
speed of the treadmill also remained the same as the previous acute exercise protocol. 
Statistical Analysis 
An independent samples T test was used on descriptive variables to compare the 
differences in the mean between obese and lean participants. A paired samples T test was used to 
compare the difference in glycerol concentrations from the pre exercise to exercise timepoints 
within each group (obese, lean). We used an independent samples T test to compare the mean 
change in glycerol concentrations from pre exercise to exercise between the obese and lean. To 
examine the effects of 16 weeks of aerobic exercise training on the obese, we used a paired 
samples T test on descriptive variables from pre training to post training. Subcutaneous AAT 
response to training was analyzed by a paired samples T test to compare the mean change in 
glycerol concentrations during exercise on the two microdialysis days (pre training change vs. 
post training change). All values are expressed as the mean ± standard error. Significance level 
was set at p < 0.05.  
  
CHAPTER 5: Results 
Aim 1 
Descriptive characteristics of both obese and lean participants are shown as the mean plus 
or minus the standard deviation of the sample (Table 1).  The sample includes 28 obese and 12 
lean children. 
Table 1  
Descriptive Statistics      
 Obese (n=28) Lean (n=12) Range 
Variable Mean ± SD Mean ± SD Min Max 
Age (yrs) 9.8 ±  0.9 9.5 ± 1.1 8 11 
Height (cm) 147.4 ±  8.2 146.1 ±  10.4 133.0 170.0 
Weight (kg) 58.5 ±  14.6 36.9 ±  7.1 30.4 85.9 
BMI (%) 96.6 ±  4.5 56.1 ±  1.3 15 37 
Total FM (kg) 24.4 ±  9.0 7.4 ±  2.3 4.0 41.0 
Note:  Participants >95th percentile in BMI are classified as obese. Participants <80th percentile in BMI are 
classified as lean. The obese had a body fat % >40% and the lean had a body fat % <28%. 
 
Oxygen Uptake, Heart Rate, and Rating of Perceived Exertion Results 
All participants performed a maximal oxygen uptake protocol on a treadmill for a test of 
fitness. The same participants also performed an acute bout of moderate exercise on the day of 
microdialysis. VO2 and heart rate data obtained are shown as the mean ± the standard deviation 
(Table 2). Maximum heart rate was obtained from the maximal VO2 protocol. The acute heart 
rate and Rating of Perceived Exertion (RPE) indicates the averages obtained during the last 15 
minutes (steady state) of the acute bout of exercise on the day of microdialysis. 
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Table 2  
VO2 Statistics  
 Obese (n=28) Lean (n=12) Range 
Variable Mean ±  SD Mean ±  SD Min Max 
Weight (kg) 58.5 ±  14.6 36.9 ±  7.1 30.4 85.9 
VO2 (ml·kg
-1·min-1) 38.5 ± 6.8 41.5 ± 7.1 22.4 63.2 
Max HR (bpm) 196.7 ±  7.5 201.0 ±  9.5 182 218 
 Acute HR (bpm)1 135.3 ±  6.8 138.3 ±  7.4 120 151 
 Acute RPE1 5.0 ±  3.1 5.2 ±  2.8 0 9 
Note:  Participants >95th percentile in BMI are classified as obese. Participants <80th percentile in BMI are 
classified as lean. The obese had a body fat % >40% and the lean had a body fat % <28%. 
1 Denotes statistics obtained from acute exercise during microdialysis day. 
Lipolysis Response (Dialysate Glycerol) to Acute Exercise 
The change in dialysate glycerol concentrations (µM) from pre exercise to exercise are 
shown as the mean plus or minus the standard error. (Figure 1) A student’s T test between the 
mean change in glycerol dialysate concentration of the obese (8.1 ± 2.1 µM) was significantly 







Blood Flow Response to Exercise (Ethanol O:I ratio) 
The change in blood flow from pre exercise to exercise is shown as the mean ± the 
standard error (Figure 2). The change in blood flow in the obese was slightly negative (-0.02 ± 
0.04) and the change in lean was slightly positive (0.08 ± 0.05). An independent samples t test 


























Figure one shows the change in glycerol concentration of obese (n = 28) and lean (n = 12) children in 
response to aerobic exercise at 70 % HRmax. Dialysate glycerol (µM) was obtained from a microdialysis probe
inserted 2 cm from the umbilicus.





Descriptive characteristics for the obese children who received the exercise intervention 
are shown as the mean ± the standard deviation (Table 3). 21 participants completed the 
intervention successfully. Participants increased height and weight (6.3 ± 7.7 cm and 2.1 ± 20.2 
kg respectively) during the 16 weeks of aerobic training. However, body fat mass did decrease 





























Figure two shows the change in blood flow (O:I) of obese (n = 28) and lean (n = 12) children in response to 
aerobic exercise at 70 % HRmax. Ethanol was obtained after perfusion througha microdialysis probe inserted 
2 cm from the umbilicus.
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Table 3  
Participant Characteristics  
 Obese (n=21)  
 Pre training Post training  Paired T test 
Variable Mean ±  SD Mean ±  SD Change p value 
Height (cm) 148.0±  8.0 151.6 ±  7.1 6.3 ±  7.7 0.4559 
Weight (kg) 59.5 ±  13.5 61.2 ±  13.8 2.1 ±  20.2 0.6428 
Body Fat (%) 41.8 ±  5.6 40.5 ±  6.1 -0.9 ±  2.8 0.2251 
Total FM (kg) 24.9 ±  8.1 25.3 ± 7.9 -0.4 ± 1.7 0.3333 
BMI (%tile) 97.1 ± 1.7 97.3 ±  1.9 0.8 ±  1.7 0.6605 
Note:  All participants completed 16 weeks of aerobic exercise training. P values produced from a Paired Samples 
T test. 
Oxygen Uptake and Heart Rate After Training 
Descriptive VO2 data for the 21 obese participants is shown as the mean ± the standard 
deviation (Table 4). Statistical analysis by a paired T test is also represented. VO2max increased 
from 1.9 ± 0.4 before training, to 2.0 ± 0.3 after training. After the aerobic training, heart rate 




Table 4  
Obese Intervention VO2 Statistics  
  Obese (n=21)   
 Pre training Post training  Paired T test 
Variable Mean ±  SD Mean ±  SD Change P Value 
Weight (kg) 59.5 ± 13.5 61.2 ± 13.8 2.1 ± 20.2 0.6428 
VO2 (l/min) 1.9 ± 0.4 2.0 ± 0.3 0.1 ± 0.2 0.0016** 
Acute HR (bpm)1 134.8 ± 7.0 127.2 ± 11.8 -7.6 ± 10.3 0.0032** 
Acute RPE1 4.7 ± 3.1 3.3 ± 2.5 -1.3 ± 2.7 0.0531 
Note:  Participants >95th percentile in BMI are classified as obese. The obese had a body fat % >40%. Pre 
training refers to testing on the first microdialysis procedure. Post Training refers to testing on the second 
microdialysis procedure. 
1Denotes statistics obtained from acute exercise during microdialysis day. 
**Denotes significance of P<0.01 
Lipolysis Response (Dialysate Glycerol) to Aerobic Training 
 Descriptive statistics for the obese participants that received the exercise intervention are 
shown as the mean ± the standard error (Table 4). Twenty-one participants completed the 
intervention successfully. The average change in glycerol concentration was higher before the 
exercise intervention (9.5 ± 2.4 µM) than after the intervention (6.6 ± 2.7 µM) in response to 































Figure one shows the change in glycerol concentration of obese (n = 21) children in response to aerobic exercise
at 70 % HRmax both before and after 16 weeks of aerobic exercise training. Dialysate glycerol (µM) was 
obtained from a microdialysis probe inserted 2 cm from the umbilicus.
    
 
CHAPTER 6: Discussion 
The review of the literature revealed few studies in lipolysis of subcutaneous AAT in 
children. In this study we measured the glycerol concentrations of subcutaneous AAT in both 
obese and lean sedentary children ages 8-11 during an aerobic bout of exercise. Obesity was 
defined as having a Body Mass Index (BMI) > 95th percentile and the lean was defined as 
having a BMI < 80th percentile. Sedentary was defined as participating in less than thirty 
minutes of structured exercise three days per week. The obese (n =28) group had approximately 
double the amount of participants when compared to the lean (n = 12).  
In response to exercise, the obese raised their subcutaneous AAT lipolysis by an average 
of 8.1 ± 2.1 µM during exercise. The lean raised their lipolysis by an average of 17.1 ± 4.2 µM 
during the same exercise. Statistical analysis of the changes between obese and lean children in 
response to exercise revealed that the obese change was significantly less when compared to the 
lean (p <0.05). These results suggest that lipolysis from subcutaneous AAT is less in obese than 
lean children in response to an acute exercise bout. These findings are in agreement with other 
studies involving obese and lean adults (Berlan et al. 2000; Mittendorfer et al. 2004), that found 
a reduced lipolytic response to exercise in obese adults when compared to lean. However, these 
results disagree with a childhood study (Hershberger et al. 2004) in which no difference was 
reported between obese and lean children in response to exercise. These differences may be 
attributed to the high variability within each group. Our individual glycerol concentrations 
included both positive and negative changes. Also, this study used a different intensity during the 
acute bout of exercise before the training intervention. Hershberger et al. (2004) used a heart rate 
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of 140 beats per minute for all children regardless of fitness level. Our study used intensities 
relative to that of the child’s maximal heart rate (70%).  
Though all children recruited in both studies were defined as sedentary, fitness levels 
may not have been equivalent. As suggested by previous studies (Despres et al. 1984; Hickner et 
al. 1999; Pillard et al. 2007), fitness level and intensity are major factors in the lipolytic response 
to catecholamines. Previous studies have also shown an increased catecholamine response when 
exercising at 50% - 70% VO2max with the latter causing an even greater increase (Hickner et al. 
1999; Wahrenburg et al. 1987). Our intensity was chosen to elicit a catecholamine response but 
one that would not interfere with the substrate utilized during the exercise bout. 
 Studies in adults suggest that hypertrophy of the adipocyte is related to functional 
changes in cell maintenance (Arner 2005; Coppack 2005; Large et al. 1998). Excess FAs are the 
cause of the hypertrophy and may interfere with the cells signaling in response to the 
catecholamines released by the sympathetic nervous system.  It has been hypothesized that these 
changes may cause alpha2 AR dominance in subcutaneous AAT of obese adults during exercise 
(Stitch et al. 2000). Evidence exists for resistance to catecholamines by adipocytes in obese 
adults and obese children (Bougnères et al. 1997; Eliakim et al. 2006; Reynisdottir 1994; Stitch 
et al. 2000).  This resistance was only observed in the subcutaneous adipose tissue and indicates 
that it is not a whole body resistance but a local one. Unfortunately, due to the delimitations of 
this study, we were not able to measure the catecholamine response from exercise or the 
response of the subcutaneous AAT to the catecholamines. More studies are needed to answer 
whether or not the function of the ARs caused this blunted lipolytic response to exercise in the 
obese children.  
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It is unclear whether adipose tissue blood flow (ATBF) played a role in the results of this 
study. Studies have shown that the obese have a lower blood flow to the subcutaneous AAT. 
This is according to the outflow/inflow ratio (O:I ratio) which is inversely related to blood flow 
(Hickner et al. 1991; Hickner et al. 1999). In this study, we found no statistical differences (p 
=0.14) in the change of subcutaneous AAT blood flow between the groups (obese; lean) during 
the two timepoints (pre exercise and exercise) we measured. We did not get full recovery in our 
dialysate so the concentrations expressed are not a direct measurement of interstitial glycerol 
concentration or of lipolytic rate. However, both obese and lean started from the same average 
glycerol concentration (47.7 ± 6.6 µM; 48.1 ± 3.9 µM respectively) at the pre exercise timepoint. 
Therefore, a mean change score was the most appropriate analysis. It is unclear if nutrition 
played a role at any point during the lipolytic response to exercise. The normal response to a 
meal is antilipolitic (insulin) (Coppack et al. 2001). The children were fed a calorically 
controlled meal 1.5 hours prior to exercise but stomach emptying or digestion was not controlled. 
Also, total caloric intake was based on body weight and therefore inherently different in total 
caloric content between the obese and lean. However, both obese and lean started from the same 
baseline glycerol concentration (pre exercise) in our first analysis. 
 The review of literature showed few studies involving microdialysis of subcutaneous 
AAT in obese children, and no studies focused on the training adaptations of this depot. It is 
believed that obese adults have a blunted lipolytic response of subcutaneous AAT to aerobic 
exercise because of the dominance of the antilipolytic effects of the alpha2 ARs (Stitch et al. 
2000). This is a trait not evident in the lean or the trained individuals (Arner et al. 1990). 
Endurance training has been shown to decrease the antilipolytic effect of the alpha2 ARs in obese 
and overweight men regardless of weight loss (Glisezinski et al. 1998; Glisezinski et al. 2003). 
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Other investigators have suggested that training increases the sensitivity of subcutaneous AAT to 
catecholamines (Crampes, Beauville, Riviere, Garrigues 1986). There is consensus in the science 
community that aerobic training causes changes, whether they are due to the availability of 
catecholamine or the receptors that bind to it, that are evident in the subcutaneous AAT of obese.  
In this study, we also measured the change in lipolytic response of obese children (n =21) 
ages 8-11 to an acute bout of exercise before and after 16 weeks of aerobic exercise training. All 
children were ≥ 95th percentile in BMI. Subcutaneous AAT glycerol concentrations from two 
separate microdialysis procedures (pre training, post training, Figure 2) were compared to 
examine differences in lipolytic rate brought on by aerobic exercise training. A paired samples T 
test revealed that the mean changes in glycerol concentration before (8.9 ± 2.4 µM) and after (6.2 
± 2.8 µM) training were not significantly different (p = 0.369). These results may suggest that 16 
weeks of aerobic exercise training decreases lipolytic rate. However, the design of this study did 
not control for the increased fitness level. A paired samples T test indicated that the obese 
children raised their aerobic capacity in response to the 16 weeks of training (p<0.05). However, 
the speed of the treadmill was the same during both microdialysis testing days. We used a given 
relative intensity (70% of maximum heart rate) during the acute exercise on the microdialysis 
day before the training intervention. However, on the second microdialysis, after training, we 
used the same treadmill speed (same absolute exercise intensity) during the acute bout of 
exercise as that used on the previous microdialysis acute exercise bout. If the same relative 
intensity had been used both before and after aerobic training, it is likely that plasma 
catecholamine concentrations, and therefore lipolysis, would have been higher after, as compared 
to before, training (Greiwe et al. 1999). There are also many other regulators of lipolysis that 
were not controlled for in this study but have been established regulators of lipolysis in adults 
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(Lafontan et al. 2009). Though we hypothesized that aerobic exercise training would increase the 
subcutaneous AAT’s response to exercise in obese children, we found the opposite. However, 
these results are in agreement with other studies that have shown that subjects that are trained 
often have a lower lipolytic rate, catecholamine response, and lipid oxidation in response to 
exercise at the same absolute intensity before and after training. This decrease is due to 
adaptations during exercise that allow the body to deal with the stress of exercise as suggested by 
Wahrenburg et al. (1987). 
 In conclusion, we found a lower lipolytic response of subcutaneous AAT to acute 
exercise performed at 70% of the heart rate maximum in healthy obese children when compared 
to healthy lean children. These findings suggest that obesity is associated with a lower lipolytic 
response to exercise in subcutaneous AAT of obese children. Whether this is a cause of 
childhood obesity or an effect is unclear with the current results. Furthermore, we found that 16 
weeks of training did not increase the subcutaneous AAT response to an acute bout of exercise in 
obese children when the same treadmill speed was used both before after the training 
intervention. More studies are needed to propose clinical strategies for preventing childhood 
obesity, and subsequently adulthood obesity.
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Principal Investigator: Robert C. Hickner, Ph.D. 
Institution: Human Performance Laboratory 
Address: 371 Ward Sports Medicine Building 
Telephone Number: (252) 328-4677 
 
TITLE OF PROJECT:  Reduction in CVD risk in children through physical activity 
 
INTRODUCTION 
Your child has been asked to participate in a research study being conducted by Robert C. 
Hickner and colleagues.  This research is designed to determine the effect of physical activity on 
cardiovascular disease risk in children. 
 
We will study lean and overweight preadolescent children.  Studies will take place in the Human 
Performance Laboratory of East Carolina University and in Minges Coliseum. 
 
PLAN AND PROCEDURES 
Prior to testing, you, as a guardian(s) will read and sign this Informed Consent for research, as 
well as fill out a medical history questionnaire pertaining to your child.   
 
Your child’s participation will involve: 
 
 You will fill out a personal history form that pertains to your child.  Your child will fill out 
forms  consisting of a youth risk behavior survey, leisure time exercise questionnaire, a 
personal history form, a medical form, a 30-day physical activity recall, pediatric quality of 
life inventory, and a physical self-perception profile and children’s attraction toward 
physical activity scale 
 
 Determination of body composition using body mass index (BMI), waist-to-hip ratio 
(WHR), skinfolds, and a DEXA Scan will be conducted at the Human Performance 
Laboratory.  To calculate BMI, height and weight will be measured.  Circumference 
measures will be taken at the waist and hip to calculate WHR.  Finally, skinfold thickness of 
the tricep, subscapular (shoulder blade), abdomen, thigh, suprailium (hip bone), and calf will 
be taken on the right side of the body, in duplicate, with a skinfold caliper.  Your child will 
undergo a test of body composition called a DEXA scan.  It is like an x-ray of your entire 
body.  During this test your child will be asked to wear minimal clothing (e.g., swimsuit, or 
shorts and a shirt, or a gown), and to remove all jewelry.  He/she will lie still on a padded 
table for the length of the scan (approximately 6 minutes).  The table will move across and up 
and down to scan his/her body.  Your child will not feel anything and can breathe normally 
during the scan.  If your child has metal in his/her body, then your child will not be able to 
participate in the DEXA scan.  Radiation exposure from a DEXA scan is approximately 0.04 
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mrem.  The effective radiation exposure that your child would receive in this study is less 
than 0.6% of the radiation exposure an individual receives from natural background sources 
in one year.  
 Determination of Aerobic Capacity  
Two maximal treadmill tests will be completed to evaluate initial aerobic capacity. Two tests 
will be performed to assure that there is adequate effort by the children during the maximal 
treadmill test and to determine day-to-day variability in the test. If these two tests are not 
very similar, a third test may need to be conducted, so it is important that your child put out a 
maximal effort for this test. For this test, your child will walk or run on a treadmill for 
approximately 10-15 minutes. During this test, your child will wear a mouthpiece so the air 
they breathe out can be collected for analysis of oxygen. At first, your child will walk 
leisurely on the level treadmill, but the speed and level of hill climbing will become harder 
until your child can no longer continue. 
 
You will be asked to complete the n-3 FFQ at baseline, 4 weeks, 8 weeks, 12 weeks, and 16 
weeks.  This will allow us to determine 1) what your child eats over time and 2) seasonal 
variations in your childs age group and population.   
 
 Your child will complete a 3 or 4 day food record at baseline (before microdialysis), 4 weeks, 
8 weeks, 12 weeks and 16 weeks. 
 
 Your child will wear a physical activity monitor (RT3 Triaxial Accelerometer) and a 
pedometer (Yamax, Japan) five days prior to microdialysis and during the microdialysis 
portion of the study.  Additionally, your child will wear the accelerometer and  pedometer for 
3 days at 4 weeks, 8 weeks, and 12 weeks. 
 
 A fasting blood sample will be obtained from an arm or hand vein.  This will involve one to 
three small needle sticks. The procedure will take place in the Human Performance 
Laboratory. 
 
 Your child will be given a cotton swab to test for salivary cortisol levels and will be 
instructed to chew on it for 45-60 seconds.  Samples will be collected at 7 a.m. (fasting), 1:45 
(prior to a standardized 2 p.m. lunch), and 30, 45, and 60 minutes after lunch.  Additional 
samples will be collected every hour on the hour from 9 a.m. to 3 p.m.  The collection of 
samples will take place in the Human Performance Lab. 
 
 At the Human Performance Lab, the insertion of up to three small probes to determine 
glycerol levels and rates of lipolysis will take place.  This probe, called a microdialysis 
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probe, is a small flexible piece of plastic tubing (about an inch long and the width of a 
needle) that is inserted through the skin, and then through the subcutaneous fat about 1/8 to 
1/4 inch below the skin of the stomach.  First, to numb the area of insertion, a topical cold 
spray (ethyl chloride) or a numbing creme (Emla creme) will be applied to the skin.  A 
needle surrounded by plastic tubing will be inserted into the subcutaneous fat of your child’s 
stomach.  The needle will be taken out of the fat and replaced with the small piece of tubing.  
The tubing will not be located in a blood vessel but between fat cells.  A Ringer solution (a 
saline/salt-water solution) will be pumped through the piece of tubing to monitor blood flow 
and fat break down in the fat tissue.  The pumped fluid will be harmless to your child since it 
is similar to the fluid already present between the cells of the body.  The Ringer solution will 
be pumped at a rate of no more than 5 microliters per minute (equivalent to a very tiny drop).  
Your child will not feel the presence or effects of this solution.  Samples will be collected 
every hour while your child is at ECU and at home for the remainder of that day until the 
following morning. Only one overnight sample will be collected when your child wakes up 
the following morning. 
 
 After the microdialysis pump is set up, your child will participate in activities pre-planned 
and provided by the study investigators.  Activities will take place in Minges Coliseum.  
Possible activities will include walking on a treadmill, riding a stationary cycle ergometer, 
roller-skating, and jump roping.  Other activities will include watching movies and playing 
board games.  All activities will be monitored by a trained exercise physiologist who is 
familiar with the usage and safety precautions for each activity.  By no means will your child 
be limited in what he/she can do during the day, except for activities that involve rough 
physical contact (for example, football). 
 
    The full day monitoring will take place on a day that the child is already out of school 
      (i.e. vacation, weekend). 
 
 If your child is randomized (similar to picking groups by flipping a coin) to the 16-week 
physical activity program, he/she will undergo all testing described above (preliminary 
measurements and a separate visit of approximately 8 hours for microdialysis in the lab) 
before and after the 16 week program. If your child is randomized to the control group that 
does not participate in the 16 week physical activity program, they will be required to 
undergo only the preliminary measurements and another visit (microdialysis) of 
approximately 8 hours in the lab.    
                                                             
RISKS AND DISCOMFORTS 
There are certain risks and discomforts that may be associated with this research.  They include: 
 
 The total amount of blood drawn for fasting blood draw is negligible.  There is an extremely 
small risk of local hematoma or infection associated with the needle stick. 
 
 Insertion of the microdialysis probe is associated with mild discomfort, similar to that 
experienced during an intramuscular injection.  Your child will not feel discomfort from the 
substances (for example, Ringer solution) pumped through the microdialysis probe.  Risks 
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associated with this procedure are small, and include hematoma (swelling and bruising) and 
infection.  To minimize the risk of hematoma or infection associated with the insertion of the 
microdialysis probes into the subcutaneous adipose tissue, these procedures will be 
performed using sterile techniques. The probes are also made of biocompatible materials. 
 
 There are some risks associated with physical activity such as bumps, bruising, scrapes and 
other injuries associated with active children. 
 
 Risks associated with the maximal exercise are dizziness, ventricular arrhythmia (odd 
heart beats), and in very rare instances death. These risks are very small, with an 
incidence of fewer than 1 in 10,000 deaths in patients who are known to, or suspected of, 
having heart disease. The risk is expectedly much smaller than this in a group of young, 
healthy subjects. To further minimize the risk, faculty and students that have been 
extensively trained in administering maximal exercise tests will administer the 
assessments. If during a test a subject complains of dizziness, chest discomfort or other 
signs of exercise intolerance, the test will be promptly stopped. In the event of loss of 
consciousness, breathing or heart beat, appropriate CPR and AED administration will be 
initiated and Greenville Fire/Rescue will be notified via 911.  
 
 Risks of the body composition assessment are those associated with exposure to low 
levels of radiation. Risks will be minimized by using an FDA-approved bone density 
machine (Prodigy, GE Lunar Corp., Madison, WI). This procedure involves a minimal 
amount of radiation. 1-3 microSieverts) that is within an acceptable range as provided by 
“North Carolina Regulations for Protection Against Radiation”.  The amount of radiation 
(1-3 microSieverts) exposure of one procedure is quite minimal.  For example, radiation 
exposure is approximately 80 microSieverts on a transatlantic airline flight of 8 hours, 50 
microSieverts living in Denver, Colorado, at an elevation of 5,000 feet for approximately 
4 weeks, or 30 to 40 microSieverts during a typical chest x-ray. There is a potential risk 
to unborn children for those who are pregnant; therefore, pregnant women must not 
undergo this procedure.  
 
 




Subjects will be able to participate in supervised physical activity and games. The risks are 
minimal relative to these benefits and the benefits of gaining knowledge with respect to the role 
of cortisol in childhood obesity. 
 
TERMINATION OF PARTICIPATION 
Your child’s participation in this research study may be terminated without your consent if the 
investigators believe that these procedures will pose unnecessary risk to your child.  Your child 




COST AND COMPENSATION 
Your child will be paid $50.00 as well as prizes worth $25 for his/her time and inconvenience for 
completion of each microdialysis procedure.   
The policy of East Carolina University does not provide for the compensation or medical 
treatment for subjects because of the physical or other injury resulting from this research activity.  
However, every effort will be made to make the facilities of Brody School of Medicine, Pitt 
County Memorial Hospital available for treatment in the event of such physical injury. 
 
CONFIDENTIALITY 
Only the investigators associated with this study will have access to the data obtained.  No 
identifying information will be released.  Numeric coding, which only the primary investigator 
will have access to, will protect the identity of your child and other subjects.  Data will be 
secured in a locked filing cabinet in the office of the primary investigator in the Human 
Performance Laboratory.  The data will be kept for 7 years.  Samples will be stored in freezers at 
the Human Performance Laboratory for a maximum of 7 years.  Your child can request 
destruction (discarded into biohazard containers and disposed of by ECU biohazard personnel) of 
his/her samples at any time.   
 
VOLUNTARY PARTICIPATION 
Your child understands that his/her participation in this study is voluntary.  Refusal to participate 
will involve no penalty or loss of benefits to which your child is otherwise entitled.  Furthermore, 
your child may stop participating at any time he/she chooses without penalty, loss of benefits, or 
without jeopardizing his/her continuing medical care at this institution. 
 
RESEARCH PARTICIPANT AUTHORIZATION TO USE AND DISCLOSE 
INFORMATION 
Federal laws require that researchers and health care providers protect your identifiable health 
information.  Federal laws also require that researchers get your permission to use collected 
health information for research.  The identifiable information we will collect from subjects in 
this research project will include:   
*General Medical History including: Family health history, medications, nutrition, physical 
activity levels and body weight history. 
*Body composition information, adipose tissue blood flow and metabolism, blood levels of 
insulin, glucose, free fatty acids, and other compounds related to cardiovascular disease risk. 
The members of our research team that will have access to your information will include the 
Principle investigator, co-investigators, as well as technical and nursing personnel involved in 
this project.  Information about you will be used and released in such a way that will protect your 
identity as much as possible; however, confidentiality cannot be absolutely guaranteed.  We will 
only share your information with those individuals listed above.  If we need to share information 
with other individuals other than those listed, we will request your permission a second time.   
You will be given a signed copy of your authorization to release medical information for 
your records.  You can limit the amount and type of information that is shared and you must 
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make this request in writing; however, the researcher is able to use any and all information 
collected prior to the request not to disclose information.  Although you can limit the release of 
your medical information, withholding some information may cause you to become ineligible for 
this research project.  Because research information continues to be looked at after a study is 
finished, it is difficult to say when the use of your information will stop.  There is currently not 
an expiration date for the use and disclosure of your information for this study. 
 
 
PERSONS TO CONTACT WITH QUESTIONS 
If you have questions related to the sharing of information, please call Robert Hickner at 252-
737-4677 (days) or 252-353-5556 nights or weekends or Joseph Garry, M.D. at 744-1953 (days) 
or 353-2825 (nights and weekends).  You may also telephone the University and Medical Center 
Institutional Review Board at 252-744-2914.  In addition, if you have concerns about 
confidentiality and privacy rights, you may phone the Privacy Officer at Pitt County Memorial 
Hospital at 252-847-6545 or at East Carolina University at 252-744-2030. 
 
CONSENT TO PARTICIPATE 
Your child certifies that he/she has read all of the above information, asked questions, and 
received answers concerning areas he/she did not understand, and have received satisfactory 
answers to these questions.  Your child willingly consents for participation in this research study.  
(A copy of this consent form will be given to the person signing as the subject or as the subject’s 
authorized representative.) 
 
Participant’s Name (Print) 
 
 
Authorized Representative’s Name (Print) – Guardian #1                                                
 
 
Signature of Authorized Representative – Guardian #1     Date                                    
 
 
Authorized Representative’s Name (Print) – Guardian #2                                                 
 
 
Signature of Authorized Representative - Guardian #2                       Date 
 
 
AUDITOR WITNESS:  I confirm that the contents of this consent/assent form were orally 
presented. 
 





Signature of Auditor                                                                         Date 
 
 
Principal Investigator’s Name (Print) 
 
 
Signature of Principal Investigator                                                    Date    
 
FUTURE TESTING OF BLOOD/MICRODIALYSIS SAMPLES 
Upon termination of this study, the blood and urine samples collected for this study will be 
stored for up to 10 years to research scientific questions specifically related to cardiovascular 
disease risk in children. I will continue to be the owner of the samples and retain the right to 
have the sample material destroyed at any time during this study by contacting the study 
principal investigator. During this study the samples will be stored with number identifiers only; 
however, the number identifier will be linked to a specific name and will be kept on file in the 
possession of the principal investigator. The linked file will be stored password protected on the 
Principal Investigator’s computer with CD backup. No other individuals will have access to 
these identifying materials unless the principal investigator is required by law to provide such 
identifying information. Data will not be publicly available and participants will not be 
identified or linked to the samples in publication. If a commercial product is developed from this 
research project, I will not profit financially from such a product. 
 
CONSENT TO PARTICIPATE IN FUTURE TESTING OF BLOOD SAMPLES  
 
I certify that I have read all of the above, asked questions and received answers concerning areas 
I did not understand, and have received satisfactory answers to these questions. I willingly give 
my consent for participation in this research study.  (A copy of this consent form will be given to 
the person signing as the subject or as the subject’s authorized representative.) 
 
CONSENT TO PARTICIPATE 
Your child certifies that he/she has read all of the above information, asked questions, and 
received answers concerning areas he/she did not understand, and have received satisfactory 
answers to these questions.  Your child willingly consents for participation in this research study.  








Authorized Representative’s Name (Print) – Guardian #1                                                
 
Signature of Authorized Representative – Guardian #1     Date                                    
 
Authorized Representative’s Name (Print) – Guardian #2                                                 
 
Signature of Authorized Representative - Guardian #2                       Date 
 
AUDITOR WITNESS:  I confirm that the contents of this consent/assent form were orally 
presented. 
 
Auditor’s Name (Print) 
 
Signature of Auditor                                                                         Date 
 
Principal Investigator’s Name (Print) 
 
Signature of Principal Investigator                                                    Date    
                                                                                   
    
 
APPENDIX C: Minor Assent Form 
Assent Document for Children 
Principal Investigator: Robert C. Hickner, Ph.D. 
Institution: Human Performance Laboratory. 371 Ward Sports Medicine Building 
Telephone Number: (252) 737-4677 
TITLE OF PROJECT: Reduction in CVD risk in children through physical activity 
You have been asked by Dr. Robert Hickner and workers in the Human Performance Lab to be 
part of a research project at East Carolina University.  In this project, you will do several 
different things.  
  
1. You will fill out forms about physical activity habits, including forms consisting of a 
youth risk behavior survey, leisure time exercise questionnaire, a medical form, a 30-day 
physical activity recall, pediatric quality of life inventory, and a physical self-perception 
profile and children’s attraction toward physical activity scale 
 
2.  You will have your height, weight, and skinfolds and percent body fat measured.  
Skinfolds are  
measured by pinching different areas of fat on your body.  You may feel a very light 
pinch.  You will then go to another room where we will do a test called a DEXA Scan.  It 
is like an x-ray of your entire body.  During this test you will wear shorts and a shirt, or a 
gown, and you will take off any jewelry.  You will then lie still on a padded table for 
about 6 minutes.  The table will move across and up and down to scan your body, but you 
do not feel anything and can breathe normally during the scan.   
 
3.  You will come to the Human Performance Lab for a day (7 a.m. to 3 p.m.), where you 
will  
     be able to play fun games, watch movies, and make new friends.   
 
4.   Someone at the lab will draw blood from a vein in your arm or hand. The needle stick 
will  
only hurt for a few seconds, although we may need to try up to three times if we do not 
get the blood on our first try.  
 
5.  You will have a small needle put into the fat under the skin of your stomach.  You may 
feel  
      a slight sting, but Dr. Hickner will try to make sure that this hurts as little as possible by  
      spraying a cold spray or putting a cream on your stomach to numb your skin.  A small  
      plastic tube (as thin as a piece of thread) will be put through this needle under your skin.  
      The needle will then be taken out after the plastic tube is in place. The plastic tube will 
then  
 be hooked up to a little pump (smaller than a Walkman). You will have three of these 
needle sticks and plastic tubes put under the skin of the stomach. A liquid, called 
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Ringer’s solution, will be pumped through the plastic tubes.  This solution will help 
measure the break down of fat in your tissue. You will wear the pump on a belt while you 
are at ECU and while you are at home on this day until the next morning. You will have 
this test done before and after the 16-week physical activity program. 
 
6.  You will wear activity monitors, which looks like a pager, for 5 days prior to the day visit, 
and during the day visit.  Additionally, you will wear the activity for 3 days during weeks 
4, 8, and 12.  You will 
wear the monitors on your belt or clothes. 
 
7.    You will participate in a maximal exercise test on the treadmill. For this test, you will 
walk or run on a treadmill for approximately 10-15 minutes. During this test, you will 
wear a mouthpiece so the air you breathe out can be collected. At first, you will walk on 
the level treadmill, but the speed and level of hill climbing will become harder until you 
can no longer continue. You will go through this test on two separate days. If these two 
tests are not very similar, a third test may be needed, so it is important that you put out a 
maximal effort for this test. 
 
8. You will participate in a 16-week physical activity program where you will skate, ride 
bicycles, and play active games. You will need to come to the activity center 3 to 4 times 
per week for at least one hour per time. 
9. You will be asked to complete a 3 or 4 day food records at baseline (before 
microdialysis), 4 weeks, 8 weeks, 12 weeks and 16 weeks. 
10. Your personal information and samples collected will be kept private and safe in the 
Human 
Performance Lab. Only Dr. Hickner and co-workers will have access to your data. If you 
decide that you want you samples thrown out, your samples will be gotten rid of properly 
by workers at ECU. 
 
 
 Child's Name  (print)                                                                        (Date)          
 
 
 Child's signature                                                                         (Date)          
 
PERSONS TO CONTACT WITH QUESTIONS 
The investigators will be available to answer your (or your guardian’s) questions concerning this 
research, now or in the future.  You or your guardian(s) may contact the investigators, Robert 
Hickner, Ph.D. at 737-4677 (days) or Joseph Garry, M.D. at 744-1953 (days) or 353-2825 
(nights and weekends).  Also, if questions arise about your rights as a research subject, you or 
your guardian(s) may contact the Chairman of the University and Medical Center Institutional 




CONSENT TO PARTICIPATE 
You certify that you have read all of the above information, asked questions, and received 
answers concerning areas you did not understand, and have received satisfactory answers to 
these questions.  You willingly consent for participation in this research study.  (A copy of this 




Authorized Representative Name (Print) – Guardian #1                                               
 
Signature of Authorized Representative – Guardian #1          Date 
 
Authorized Representative Name (Print) – Guardian #2                                                 
 
Signature of Authorized Representative – Guardian #2                  Date 
 
AUDITOR WITNESS:  I confirm that the contents of this consent/assent form were orally 
presented. 
 
Objective Third Party Witness Name (Print) 
 
Signature of Objective Third Party Witness         Date 
 
Principal Investigator’s Name (Print) 
 
Signature of Principal Investigator                                                                                         Date   
    
 
APPENDIX D: VO2max Treadmill Protocol 
Treadmill Tech: ___________ 
 
Ht.______Wt.______ DOB:________ Previous(_______) TTE:______, Max HR_____, Max BP_______ 
 
Subject _________________________________  Age ___________ Date ________________ 
 
Age-Predicted Maximum HR ______________________ 85%______________________________ 100% 
 
Sitting: HR ____________ BP _____/______/_____  
_____________________________________________________________________________________ 
                 Stage       SPEED     GRADE                     HEART                 RPE                         COMMENTS 
                 (min)        (mph)          (%)               RATE                                                          BP 
    Submax   1   ______           0                _____    __________________ 
       (1)       2         ______           0   _____                  _______  __________________ 
       2.5       3         ______           0   _____                  _______  Blood Pressure  
                   4         ______           0   _____                  _______  __________________ 
                   5         ______           0   _____                  _______  ________/_________ 
     (140)       
 Submax   6         ______           0   _____  _______  __________________ 
        (2)      7          ______           0   _____  _______  __________________ 
     Hr 140   8         ______            0                              _____  _______  Blood Pressure 
                   9         ______            0   _____  _______  __________________ 
                   10       ______            0   _____  _______  ________/_________ 
     
 VO2 max   11       ______            0   _____  _______  __________________ 
                   12       ______            2   _____  _______  __________________ 
         13       ______            4   _____  _______  __________________ 
            14       ______            6   _____  _______  __________________ 
           15       ______            8   _____  _______  __________________ 
           16       ______           10               _____  _______  __________________ 
          17       ______           10               _____  _______  __________________ 
           18       ______           10               _____  _______  __________________ 
           19       ______           10               _____  _______  __________________ 
           20       ______           10               _____  _______  __________________ 
           21       ______           10               _____  _______  __________________ 
          22       ______           10               _____  _______  __________________ 
           23       ______           10               _____  _______  __________________ 
           24       ______           10               _____  _______  __________________ 
           25       ______           10               _____  _______  __________________ 
 
 
Total Treadmill Time ___________  Max HR __________  Max BP __________  Max RPP___________ 
 
Test Terminated Due To:_________________________________________________________________ 
 
Recovery:   Active _________  Supine ___________ 
 
Time  Heart  Blood Pressure           Comments 
  min                      Rate                      (if needed) 
   1                        _____   
   2           _____ 
   3                        _____                    _____/______                          ____________
    
 
APPENDIX E: Acute Exercise Protocol 
Acute Exercise 
Date:         Participant ID: 
Time:         Max HR: 




Minute  Heart rate Speed  RPE  Comments 
 
1  ________ ______   ________________________ 
2       ________ ______   ________________________ 
3     ________ ______ _____  ________________________ 
 
20 minute exercise bout at 70% of HR max 
 
4    ________ ______   ________________________ 
5    ________ ______ _____  ________________________ 
6    ________ ______   ________________________ 
7    ________ ______   ________________________ 
8    ________ ______ _____  ________________________ 
9    ________ ______   ________________________ 
10    ________ ______ _____  ________________________ 
11    ________ ______   ________________________ 
12    ________ ______ _____  ________________________ 
13    ________ ______   ________________________ 
14    ________ ______ _____  _______________________ 
15    ________ ______   ________________________ 
16    ________ ______ _____  ________________________ 
17    ________ ______   ________________________ 
18    ________ ______ _____  ________________________ 
19    ________ ______   ________________________ 
20    ________ ______ _____  ________________________ 
21    ________ ______   ________________________ 
22    ________ ______ _____  ________________________ 




24   ________ ______   ________________________ 
25   ________ ______   ________________________ 




Avg. HR of the last 15 min. of exercise (steady state)________                                            
Avg. treadmill speed the last 15 min. of exercise (steady state)________
    
 
 
 
